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Chromaffin cells from adult bovine adrenal medulla were found to develop neurites when cocultured with 
pituitary intermediate lobe (IL) cells. In coculture 51.7% of the chromaffin cells extended neurites compared 
with 12% in control cultures (chromaffin cells alone). A soluble factor released by IL cells was apparently 
involved as medium conditioned by contact with IL cells also promoted neurite outgrowth. Moreover, the 
addition of rMSH, one of the pro-opiomelanocortin-derived peptides secreted by IL cells, alone reproduced 
this effect in a dose-dependent manner. The data provide evidence for a neurotrophic role of aMSH. 
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1. INTRODUCTION 
a-Melanocyte stimulating hormone (cuMSH) is a 
pro-opiomelanocortin-derived peptide produced 
mainly in the pituitary intermediate lobe (IL) [l], 
but also in the central [2,3] and peripheral [4] ner- 
vous systems. Though the peptide alters pigmenta- 
tion in lower vertebrates, the role of aMSH in 
mammals is still unknown. Behavioural studies 
suggest that the peptide could influence neuronal 
function: in rodents aMSH modifies learning and 
avoidance responses [5] and such indirect evidence 
indicates that aMSH might enhance peripheral 
nerve regeneration [6]. All of this could be com- 
patible with (YMSH having a role in neuronal 
plasticity. Cultured chromaffin cells from bovine 
adrenal medulla provide a useful model to test 
aMSH neurotrophic properties because these cells 
can be induced to adopt a neurone-like phenotype 
(‘transdifferentiation’) under certain culture con- 
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ditions [7-121. In our system we put two cell 
groups into coculture: adult bovine chromaffin 
cells and porcine pars intermedia cells as a source 
of aMSH. We found that in serum-free condi- 
tions, the presence of IL cells or conditioned 
medium from such cells dramatically increased 
neurite outgrowth from the chromaffin cells. 
Moreover, N-acetylated aMSH and desacetylated 
(uMSH, but not ACTH were shown to reproduce 
this neurotrophic effect. 
2. MATERIALS AND METHODS 
2.1. Preparation of cultures 
Briefly, porcine neurointermediate lobes were 
placed in a dissociation medium (0.2% dispase, 
0.1% collagenase and 0.05% hyaluronidase) for 
30 min. After rinsing the lobes were dissociated in 
0.05% trypsin for 15 min, then resuspended in 
plating medium [13]. Chromaffin cells were 
isolated from bovine adrenal medulla by 
retrograde perfusion with collagenase and purified 
on a self-generating Percoll gradient [14]. 
Cells were plated at 2 x lo5 cells/35 mm dish on 
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collagen-coated glass coverslips. For cocultures, 
1 x lo5 of each cell type were plated together. 
Plating medium was 50% Dulbecco’s modified 
Eagle’s medium (DMEM). 50% Ham F12, pH 7.2, 
supplemented with 10% fetal calf serum, penicillin 
(1 pug/ml), streptomycin (1 ,ug/ml), kanamycin 
(0.1 mg/ml), glutamine (0.286 g/l), glucose 
(1.8 g/l) and sodium bicarbonate (2 g/l). After 
allowing 60 h for cell attachment, medium was 
changed to defined serum-free (N2) medium [15] 
with antibiotics as above. Thereafter, medium was 
changed every 3 days. Cytosine arabinoside 
(10e5 M) and fluorodeoxyuridine (low5 M) were 
added from day 3. Cells were grown at 37°C under 
air/CO2 (95%/5%). 
2.2. Production of conditioned medium (CM) 
Medium was ‘conditioned’ by contact .with IL 
cells (4-8 days old, lo5 cells/ml) for 24 h. This 
medium was harvested, centrifuged and diluted 
1: 1 with fresh defined serum-free medium. 
2.3. Immunofluorescence 
Cells were fixed in 4% paraformaldehyde in 
0.12 M phosphate buffer (pH 7.0) and perme- 
abilized in Triton X-100 and acetone [16]. Samples 
were preincubated in 5% sheep serum to reduce 
non-specific staining and then incubated in the 
primary antibody in Tris-buffered saline (TBS: 
20 mM Tris, 150 mM NaCl, pH 7.4). Rabbit anti- 
crMSH antibody [ 17,181 was used to identify IL 
cells and rat anti-DBH [19] or rabbit anti- 
chromogranin A antibodies [20] were used as the 
chromaffin cell markers. Neurofilaments were 
marked using the mouse monoclonal NF 02.40 an- 
tibody [21]. Primary antibodies were used at a 
dilution of 1: 1000, except anti-chromogranin A 
which was diluted 1:2500. Antibodies were 
visualized using fluorescein isothiocyanate (FITC)- 
conjugated goat anti-rabbit IgG, tetramethyl- 
rhodamine isothiocyanate (TRITC)-conjugated 
sheep anti-mouse IgG (Sigma) or TRITC-con- 
jugated goat anti-rat IgG (Nordic Immunologi- 
cals) at a 1: 100 dilution in TBS. 
2.4. Neurite counts 
Cells were fixed and stained immunocyto- 
chemically for a chromaffin cell marker, either 
chromogranin A or DBH. Neurite outgrowth was 
scored by counting as positive, those cells having 
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extensions twice as long as the cell body (> 40 pm). 
For each dish, two independent counts of three 
transects, each including 100 cells, were carried 
out. 
2.5. Effects of POMC-derived peptides 
Peptides were dissolved in 0.1 M HCl, then 
diluted in defined medium to a concentration of 
10m3 M. These stock solutions were sterilised by 
filtration through 0.22 pm filters. Concentrations 
were checked by radioimmunoassay [ 171, and ap- 
propriate dilutions in defined medium carried out. 
Peptides were added to cultures from days 3 to 
10. N-Acetylated cvMSH was from Bachem, 
desacetylated L~MSH from UCB and ACTHr-24 
from Ciba Geigy. 
3. RESULTS AND DISCUSSION 
Fig.la-c shows a coculture marked with 
dopamine-,&hydroxylase (DBH) and @MSH an- 
tibodies to identify the chromaffin cells (fig.lb) 
and IL cells (fig.lc), respectively. The cuMSH- 
producing cells were spherical and often closely 
associated with the chromaffin cells (fig. la). Many 
of the DBH-positive cells put out numerous 
branched or unbranched neurite-like extensions of 
at least 40pm in length, with some extensions at- 
taining 1 mm. In chromaffin cells with neurite-like 
extensions, the intensity of the DBH staining was 
often diminished in the cell body and concentrated 
in the varicosities and tips of neurites suggesting 
that chromaffin granules are transported into the 
developing extensions (fig. lb). During the third 
week of coculture, neurofilament proteins were 
detected in chromaffin cell extensions (fig. ld,e) 
demonstrating that they are analogous to neuronal 
extensions. Chromaffin cells in coculture could be 
maintained up to 3 months, whereas control 
cultures did not survive more than 3 weeks. In- 
deed, in control cultures the majority of chromaf- 
fin cells remained spherical and only a few put out 
short extensions (fig.2a). 
To determine if a diffusible factor from IL cells 
was involved in inducing neurite outgrowth, condi- 
tioned medium (CM) prepared from IL cultures 
(IL-CM) was used to culture chromaffin cells. 
Again, an increase in neurite outgrowth resulted, 
either in defined medium (fig.2b-d) or in medium 
supplemented with 5% fetal calf serum (not 
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Fig. 1. Chromaffin cells cocultured with IL cells (a-c) adopt neurone-like features (d,e). (a-c) Same field of 1 l-day-old 
coculture viewed in phase contrast (a) and after immunofluorescence staining, using anti-DBH for chromaffin cells (b) 
and anti-cwMSH to identify IL cells (c). (d,e) Fluorescent images of chromaffin cells from an 18-day-old coculture 
stained with anti-DBH (d) and anti-neurofilament (e). Note colocalization of the markers in neurites. Bar, 15 pm. 
shown). As in coculture, many chromaffin cells 
flattened and grew extensions, often branched and 
with varicosities (fig.2b). The extensions were im- 
munopositive both for the chromaffin granule 
marker, chromogranin A (fig.2c), and for 
neurofilament proteins (fig.2d). Moreover, in con- 
trast to controls, phosphorylated neurofilament 
proteins were detected in the transdifferentiated 
chromaffin cells in coculture and IL-CM (Grant, 
N. et al., submitted). 
To quantify the relative effects of coculture con- 
ditions and IL-CM on neurite outgrowth, cells 
with neurites (>40pm) were counted. As seen in 
fig.3a, the mean percentage of chromaffin cells 
developing neurites was higher in cocultures (51.7 
f 5.0070, mean k SE) than in IL-CM (37.8 + 
1.8%) and both values were significantly different 
01 < 0.001) from controls (12.0 + 1. 170). Since IL- 
CM mimics the effects observed in coculture, a 
soluble factor released by IL cells is probably in- 
volved in inducing neurite outgrowth. 
One of the products of pro-opiomelanocortin 
(POMC) proteolysis secreted from the IL is 
aMSH, which is cleaved from ACTH. CXMSH can 
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Fig.2. Comparison of cultures maintained in either control medium (a) or conditioned medium (b-d) at 21 days, or 
cvMSH at 10 days (e,f). Arrows indicate short extensions in some control cells (a) and an extensive neurite network in 
cultures grown in conditioned medium (b). Colocalization of chromogranin A (c,e) and neurofilaments (d,f) in 
chromaffin cell extensions. Bar, 15 pm. 
undergo N-terminal acetylation giving rise to the 
three forms found in IL extracts: N-acetylated (the 
form usually referred to as cuMSH), N,O- 
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diacetylated and desacetylated &MSH [ 171. We in- 
itially measured the total aMSH levels in 
cocultures and IL-CM using a C-terminal-directed 
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the aMSH molecule [23]. Only low levels of 
ACTH were present (4.0 + 1.5 ng/ml CM). We 
tested the effects of N-acetylated cuMSH, 
desacetylated aMSH and ACTH on neurite 
outgrowth from bovine chromaffin cells, using 
each peptide at 100 ng/ml, approximately the con- 
centration of aMSH found in IL-CM. N- 
Acetylated and desacetylated L~MSH were equipo- 
tent in promoting neurite outgrowth (fig.2e,f); the 
mean percentage of chromaffin cells extending 
neurites being 23.9 f 1.4% and 27.9 + 1.7%, 
respectively, compared with 11.8 f 0.5% for con- 
trols (fig.3). Interestingly, desacetylated crMSH is 
less effective than aMSH on the documented 
target for cuMSH, melanocytes, which like 
chromaffin cells are derived from the neural crest. 
However, desacetylated @MSH is the major form 
present in the developing hypothalamus [24,25], 
and may play a neurotrophic role in the brain. 
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Fig.3. Neurite outgrowth from chromaffin cells is 
increased by coculture with IL cells, by IL conditioned 
medium and by cyMSH. (Top) Percentage of cells with 
neurites in control, coculture and conditioned medium 
(CM). (Bottom) Percentage of cells with neurites in 
control, N-acetylated cvMSH (MSH) at different 
concentrations, ACTHI-= and desacetylated L~MSH 
(dMSH). All experimental groups except ACTH were 
significantly different from controls when analyzed 
using a Student’s t-test, with n = number of transects 
counted. 
antibody that recognises equally well the three 
forms of the peptide [17,18]. Medium taken from 
l-week-old cocultures and IL-CM contained 81.2 
+ 8.1 and 77.3 f 7.8 ng/ml aMSH (mean f SE, 
n = 6), respectively. Using an antibody (Patti) that 
recognises only acetylated forms of cvMSH [22], we 
found that approx. 70% of the aMSH was 
acetylated, implying that the desacetylated form 
accounted for 30% of the total aMSH secreted. 
The media were also assayed for ACTH as 
neurotropic properties have been attributed to a 
fragment of the hormone ACTHI-24 that includes 
To characterize further the aMSH effect, a 
dose-response curve was carried out using N- 
acetylated aMSH, the principal form present in 
cocultures and CM. As seen in fig.3b, the effect of 
N-acetylated aMSH on neurite outgrowth was 
dose-dependent, and even the lowest dose tested 
(0.1 ng/ml; approx. 5 x lo-” M) was significantly 
different from controls (p < 0.01). This concentra- 
tion is in the range of aMSH concentrations 
reported for cerebra-spinal fluid [26]. ACTH 
alone did not affect neurite outgrowth in chromaf- 
fin cells (fig.3b). 
The observation that coculture conditions and 
IL-CM are more effective than aMSH alone (fig.3) 
implies that other factors, perhaps POMC-derived 
molecules are involved. POMC processing gives 
rise to an array of peptides. Some of these 
neuropeptides and their derivatives have been 
shown to modify neuronal metabolism. Endor- 
phins and related peptides modify turnover of a 
number of neurotransmitters [5] and even an en- 
dorphin fragment as short as two amino acids has 
been shown to alter cholinesterase activity in 
superior cervical ganglia [27]. 
The factors which favour transdifferentiation of 
adult bovine adrenal chromaffin cells are unclear. 
Unlike cells from rat adrenals, they respond poorly 
to nerve growth factor [9-121 and are unaffected 
by dibutyryl cyclic AMP [ll]. However, they do 
respond positively to depolarizing agents [ 1 l] and 
to extracts of either bovine non-chromaffin 
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adrenal medulla cells or seminal vesicles [lo]. The 
seminal vesicle is a source of POMC-derived pep- 
tides [24], so it is tempting to suggest that some of 
the neurite promoting effects of seminal vesicle ex- 
tract might be due to such peptides. 
Our results demonstrating enhanced neurite 
outgrowth from chromaffin cells suggest that N- 
acetylated (wMSH and desacetylated aMSH must 
be added to the growing list of substances (protein 
growth factors, substrata, second messengers) 
which can influence neuronal plasticity. The pre- 
sent data coupled with the observation that aMSH 
immunoreactive neurons in the hypothalamus and 
thalamus project towards the hippocampus, 
forebrain and spinal cord [29], could implicate 
uMSH as a neurotrophic factor in the central ner- 
vous system. 
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